Kazim Cebi
Kazim Cebi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Abdulkerim Yıldız
Ministry of Health Hitit University, Erol Olçok Training and Research Hospital, Çorum, Turkey
1 shared publication - Aysel Kocagul-Celikbas
Department of Infectious Diseases and Clinical Microbiology, Hitit University School of Medicine, Çorum, Turkey
1 shared publication - Burak Yilmaz
HITIT UNIVERSITY, SCHOOL OF MEDICINE
1 shared publication - Derya Yapar
Department of Infectious Diseases and Clinical Microbiology, Hitit University School of Medicine, Çorum, Turkey
1 shared publication - Gamze Kodalak Özil
Department of Internal Medicine, Tokat Turhal State Hospital, Tokat, Türkiye
1 shared publication - Hilal Boyacı
HITIT UNIVERSITY, SCHOOL OF MEDICINE
1 shared publication
Latest Publications
- Open Access
- 29 July 2023
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 10 (7) , 500-503
Successful management of adult hemophagocytic lymphohistiocytosis with an etoposide-containing regimen: Case report and literature review
Objective: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disorder characterized by a hyperimmune response. Although HLH is well described in the pediatric population, less is known about the appropriate management in adults. Despite the inclusion of etoposide in HLH society protocols, some clinicians refrain from using it due to its cytotoxicity and potential adverse effects. Case: We report here the case of a 43-year-old male presenting with fever and pancytopenia, who was diagnosed with HLH following further evaluation. The patient immediately started the HLH-2004 initial protocol, which consisted of dexamethasone, etoposide, cyclosporine, and IVIG. Symptoms improved after 2 weeks of treatment. Subsequent bone marrow biopsy showed normal results, and the patient achieved complete remission, leading to the termination of treatment in the 12th week of the protocol. At 8 months post-treatment, the patient remained recurrence-free with normal hematological and biochemical test results. Conclusion: This case underscores the importance of considering etoposide-containing regimens, particularly for medically fit patients.
- 29 July 2023
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 10 (7) , 500-503
Open AccessSuccessful management of adult hemophagocytic lymphohistiocytosis with an etoposide-containing regimen: Case report and literature review
Objective: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disorder characterized by a hyperimmune response. Although HLH is well described in the pediatric population, less is known about the appropriate management in adults. Despite the inclusion of etoposide in HLH society protocols, some clinicians refrain from using it due to its cytotoxicity and potential adverse effects. Case: We report here the case of a 43-year-old male presenting with fever and pancytopenia, who was diagnosed with HLH following further evaluation. The patient immediately started the HLH-2004 initial protocol, which consisted of dexamethasone, etoposide, cyclosporine, and IVIG. Symptoms improved after 2 weeks of treatment. Subsequent bone marrow biopsy showed normal results, and the patient achieved complete remission, leading to the termination of treatment in the 12th week of the protocol. At 8 months post-treatment, the patient remained recurrence-free with normal hematological and biochemical test results. Conclusion: This case underscores the importance of considering etoposide-containing regimens, particularly for medically fit patients.
- Open Access
- 14 February 2022
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 4 (1) , 1-6
COVID-19 and Crimean-Congo Hemorrhagic Fever: Is there any Similarity in Chest Radiology?
Objective: While the coronavirus disease 2019 (COVID-19) pandemic was continuing at full speed, patients with Crimean-Congo hemorrhagic fever (CCHF), which is endemic in our region, apply to the emergency department simultaneously. The presence of computed tomography (CT) lesions suggesting COVID-19 in some CCHF patients has brought to our mind the question of whether there is CCHF lung involvement even though respiratory symptoms are not at the forefront. Methods: In this study, the findings of chest CT, demographic data and clinical symptoms of cases who had thorax tomography scan with suspicion of COVID-19 in the emergency department in the spring and summer of 2020 and were diagnosed with CCHF as a result of the evaluation and followed up in our clinic were compared with the findings of COVID-19 cases that were hospitalized and treated in the same period. Results: Seventy-seven COVID-19 and 25 CCHF cases were included in the study. Myalgia, headache, diarrhea, nausea and vomiting were significantly higher in CCHF patients (p p= 0.034). Ground-glass opacity (GGO) was the most common tomography finding in CCHF, and cases without lung involvement were significantly higher (p = 0.001). GGO, consolidation, vascularization, atelectasis band, reverse halo, air-bubble, nodule were significantly high in COVID-19 patients. Conclusion: During the epidemic period, no pathological finding was found in thoracic CT in most of the CCHF cases, and the presence of involvement in the lung tomography in cases with similar clinical and laboratory findings should primarily suggest the diagnosis of COVID-19. Keywords: coronavirus disease 2019, COVID-19, Crimean-Congo hemorrhagic fever (CCHF), computed tomography (CT), ground-glass opacity (GGO)
- 14 February 2022
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 4 (1) , 1-6
Open AccessCOVID-19 and Crimean-Congo Hemorrhagic Fever: Is there any Similarity in Chest Radiology?
Objective: While the coronavirus disease 2019 (COVID-19) pandemic was continuing at full speed, patients with Crimean-Congo hemorrhagic fever (CCHF), which is endemic in our region, apply to the emergency department simultaneously. The presence of computed tomography (CT) lesions suggesting COVID-19 in some CCHF patients has brought to our mind the question of whether there is CCHF lung involvement even though respiratory symptoms are not at the forefront. Methods: In this study, the findings of chest CT, demographic data and clinical symptoms of cases who had thorax tomography scan with suspicion of COVID-19 in the emergency department in the spring and summer of 2020 and were diagnosed with CCHF as a result of the evaluation and followed up in our clinic were compared with the findings of COVID-19 cases that were hospitalized and treated in the same period. Results: Seventy-seven COVID-19 and 25 CCHF cases were included in the study. Myalgia, headache, diarrhea, nausea and vomiting were significantly higher in CCHF patients (p p= 0.034). Ground-glass opacity (GGO) was the most common tomography finding in CCHF, and cases without lung involvement were significantly higher (p = 0.001). GGO, consolidation, vascularization, atelectasis band, reverse halo, air-bubble, nodule were significantly high in COVID-19 patients. Conclusion: During the epidemic period, no pathological finding was found in thoracic CT in most of the CCHF cases, and the presence of involvement in the lung tomography in cases with similar clinical and laboratory findings should primarily suggest the diagnosis of COVID-19. Keywords: coronavirus disease 2019, COVID-19, Crimean-Congo hemorrhagic fever (CCHF), computed tomography (CT), ground-glass opacity (GGO)